Beranda0775 • HKG
add
CK Life Sciences Intl (Holdings) Inc
Tutup sebelumnya
$0,41
Rentang hari
$0,41 - $0,42
Rentang tahun
$0,30 - $0,62
Kapitalisasi pasar
3,94Â M HKD
Volume Rata-Rata
887,22Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
HKG
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(HKD) | Jun 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 1,32Â M | 2,20% |
Biaya operasional | 323,51Â jt | -4,23% |
Laba bersih | 500,50Â rb | -97,29% |
Margin laba bersih | 0,04 | -97,20% |
Penghasilan per saham | — | — |
EBITDA | 117,12Â jt | 36,03% |
Tarif pajak efektif | 79,96% | — |
Neraca
Total aset
Total liabilitas
(HKD) | Jun 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 562,09Â jt | 11,10% |
Total aset | 10,89Â M | -1,45% |
Total liabilitas | 6,87Â M | -0,11% |
Total ekuitas | 4,01 M | — |
Saham yang beredar | 9,61 M | — |
Harga terhadap nilai buku | 0,98 | — |
Tingkat pengembalian aset | 1,75% | — |
Tingkat pengembalian modal | 1,91% | — |
Arus Kas
Perubahan kas bersih
(HKD) | Jun 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | 500,50Â rb | -97,29% |
Kas dari operasi | 72,70Â jt | 80,63% |
Kas dari investasi | -47,88Â jt | -484,81% |
Kas dari pembiayaan | -77,72Â jt | 41,39% |
Perubahan kas bersih | -57,56Â jt | 42,02% |
Arus kas bebas | 35,56Â jt | 91,21% |
Tentang
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Mr. Victor Li, the elder son of Mr. Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
CEO
Didirikan
2000
Situs
Karyawan
1.968